ORCHPHARMA — Orchid Pharma Balance Sheet
0.000.00%
- IN₹42.67bn
- IN₹41.84bn
- IN₹8.19bn
- 73
- 15
- 31
- 32
Annual balance sheet for Orchid Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,742 | 350 | 80.6 | 308 | 2,711 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,274 | 1,902 | 2,231 | 2,161 | 1,972 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,693 | 5,499 | 4,499 | 5,010 | 7,908 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8,588 | 6,775 | 5,931 | 6,192 | 6,360 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 14,599 | 12,373 | 11,106 | 12,252 | 15,539 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,749 | 1,421 | 2,408 | 3,719 | 2,600 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 6,939 | 5,843 | 4,632 | 5,366 | 3,844 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 7,660 | 6,529 | 6,474 | 6,886 | 11,695 |
Total Liabilities & Shareholders' Equity | 14,599 | 12,373 | 11,106 | 12,252 | 15,539 |
Total Common Shares Outstanding |